News and Trends 8 Mar 2023
How to promote diversity in STEM
Leaders from OMass Therapeutics, SiSaf and Brainomix explain how to promote diversity in science, technology, engineering and math (STEM). OMass…
GSK
- Latest Posts
Expert Advice 2 Mar 2023
5 steps to strategic partnerships for healthtech startups
By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities…
News and Trends 10 Feb 2023
FDA approves GSK drug for recurrent or advanced mismatch repair-deficient endometrial cancer
GSK plc says the US Food and Drug Administration (FDA) has given full approval for Jemperli (dostarlimab-gxly) for the treatment…
News and Trends 9 Feb 2023
Cell and Gene Therapy Catapult boost for life science campus
The Cell and Gene Therapy Catapult (CGT Catapult), an independent U.K. innovation and technology organization specializing in the advancement of…
ADVERTISEMENT
News and Trends 10 Nov 2022
Sanofi and GSK Covid-19 booster vaccine approved by European Commission
Sanofi and GSK’s Covid booster vaccine has been approved in Europe. After the European Medicines Agency’s Committee for Medicinal Products…
News and Trends 9 Aug 2022
Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment
A global collaboration was announced today (August 9) between Mersana Therapeutics Inc and GSK plc that will give GSK the…
News and Trends 13 Jun 2022
GSK positive on RSV vaccine for older adults
GSK plc has announced positive headline results from its AReSVi 006 phase III trial. AReSVi 006 is a phase III…
News and Trends 2 Jun 2022
Upstream Bio to target asthma as it launches with $200M financing
Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M Series A financing. The company…
News and Trends 1 Jun 2022
GSK to acquire clinical-stage biopharmaceutical company Affinivax
GSK plc is set to acquire Affinivax, Inc., a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1B…
News and Trends 30 Jun 2021
GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos
Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month, wondering if it overpaid for…
ADVERTISEMENT
News and Trends 15 Jan 2021
GSK Acne Deal Heralds Growing Interest in Skin Microbiome
This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to land a big pharma deal…
News and Trends 23 Jul 2020
Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal
GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company CureVac to co-develop messenger RNA…
News and Trends 23 Mar 2020
ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada
A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for the treatment of HIV in…
News and Trends 25 Feb 2020
Update: Janssen and Maze Jump on Board Finnish Genomics Project
Update (25/02/2020): Janssen and the US company Maze Therapeutics are the latest pharma companies to sign up as partners in…
News and Trends 20 Feb 2020
Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies
The German biotech Immatics will partner with GSK and could receive more than €1B from the big pharma for developing…
News and Trends 22 Nov 2019
ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV
The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed from the National Institutes of…
ADVERTISEMENT
News and Trends 31 Oct 2019
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to discover biomarkers that can predict…
Expert Advice 7 Aug 2019
Why Making the Jump from Pharma to Biotech Can be a Life Changing Experience
In less than two years, Orchard Therapeutics has changed from a small, relatively unknown UK biotech specializing in gene therapy…
News and Trends 3 Jul 2019
EU Approves Two-Drug Pill as First-Line Treatment for HIV
The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as a first-line treatment for HIV,…
News and Trends 4 Apr 2019
Update: Two-Drug HIV Treatment Effective for up to Three Years
Update (04/04/2019): ViiV Healthcare's two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for up to three years in…
